D-dimer testing and recurrent venous thromboembolism after unprovoked pulmonary embolism: A post-hoc analysis of the prolong extension study

Thrombosis and Haemostasis

Volumn 100, Issue 4, 2008, Pages 718-721

  Pengo, Vittorio ^a,e   Palareti, Gualtiero ^b   Cosmi, Benilde ^b   Legnani, Cristina ^b   Tosetto, Alberto ^c   Alatri, Adriano ^d   Marzot, Filippo ^a   Pegoraro, Cinzia ^a   Cucchini, Umberto ^a   Iliceto, Sabino ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

^d GENERAL HOSPITAL   (Italy)

^e Ospedale Busonera   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; D DIMER;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DRUG WITHDRAWAL; HEMOPERITONEUM; HUMAN; LEG VEIN; LETTER; LUNG EMBOLISM; POST HOC ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; VENOUS THROMBOEMBOLISM;

AGED; ANTICOAGULANTS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; VENOUS THROMBOEMBOLISM;

EID: 54949122117     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-04-0250     Document Type: Letter

References (15)

1. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.
2. Prandoni P, Lensing AW, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960.
3. Piovella F, Crippa L, Barone M, et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 2002; 87: 515-522.
4. Palareti G, Legnani C, Cosmi B, et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost 2002; 87: 7-12.
5. Palareti G, Legnani C, Cosmi B, et al. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia. Circulation 2003; 108: 313-318.
6. Eichinger S, Minar E, Bialonczyk C, et al. D-dimer levels and risk of recurrent venous thromboembolism. J Am Med Assoc 2003; 290: 1071-1074.
7. Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation Therapy. N Engl J Med 2006; 355: 1780-1789.
8. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT): Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
9. Agnelli G, Prandoni P, Becattini C, et al. for the WODIT investigators: Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 2003; 139: 19-25.
10. Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-96.
11. Pengo V, Lensing AW, Prins MH, et al. for the Thromboembolic pulmonary hypertension study group: Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257-2264.
12. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost 2002; 88: 407-414.
13. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907.
14. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. J Am Med Assoc 1998; 279: 458-462.
15. Agnelli G, Prandoni P, Santamaria MG, et al. for the Wodit investigators: Three months versus one year of oral anticoagulant therapy for idiopathic deep vein thrombosis. N Engl J Med 2001; 345: 165-169.